Skip to main content

Day: April 16, 2025

Union Bankshares Announces Earnings for the three months ended March 31, 2025 and Declares Quarterly Dividend

MORRISVILLE, Vt., April 16, 2025 (GLOBE NEWSWIRE) — Union Bankshares, Inc. (NASDAQ – UNB) today announced results for the three months ended March 31, 2025 and declared a regular quarterly cash dividend. Consolidated net income for the three months ended March 31, 2025 was $2.5 million, or $0.55 per share, compared to $2.4 million, or $0.53 per share, for the same period in 2024. Balance Sheet Total assets were $1.52 billion as of March 31, 2025 compared to $1.42 billion as of March 31, 2024, an increase of $107.2 million, or 7.6%. Loan demand was strong in 2024 and through the first three months of 2025 resulting in an increase of $128.0 million, or 12.3 %, to reach $1.16 billion as of March 31, 2025 including $4.1 million in loans held for sale, compared to $1.04 billion as of March 31, 2024, with $3.4 million in loans...

Continue reading

Toll Brothers Announces New Luxury Home Community Coming Soon to Franklin, Tennessee

FRANKLIN, Tenn., April 16, 2025 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today announced a highly anticipated new Nashville-area community, Franklin Ridge, is coming soon to Franklin, Tennessee. Site work is underway, and the community is anticipated to open for sales later this year. Conveniently located near the McEwen Interstate 65 interchange, Franklin Ridge will feature 34 exceptional single-family homes. The homes will feature 4 to 6 bedrooms and offer up to 4,350 square feet of living space. Prospective homeowners will have the opportunity of selecting from three stunning home designs, each offered with three distinct exterior designs, all crafted with the unparalleled quality, craftsmanship, and value for which Toll Brothers is renowned. Additionally, residents...

Continue reading

HAOXIN HOLDINGS LIMITED Announces Closing of Initial Public Offering

Ningbo, China, April 16, 2025 (GLOBE NEWSWIRE) — Haoxin Holdings Limited (“Haoxin” or the “Company”) (NasdaqCM: HXHX), a provider of temperature-controlled truckload service and urban delivery services in China, today announced the closing of its initial public offering (the “Offering”) of 1,750,000 Class A ordinary shares at a public offering price of $4 per share. The Class A ordinary shares began trading on Nasdaq Capital Market under the ticker symbol “HXHX” on April 15, 2025. The Company received aggregate gross proceeds of $7 million from the Offering, before deducting underwriting discounts and other related expenses. In addition, the Company has granted the underwriters an option, exercisable within 45 days from the date of the underwriting agreement, to purchase up to an additional 262,500 Class...

Continue reading

Scilex Holding Company Announces FDA Has Approved Our Request for the Orphan Drug Designation for Colchicine for the Treatment of Pericarditis

Gloperba® is the first and only liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults. Pericarditis is an inflammation of the pericardium, the sac-like membrane that surrounds and protects the heart. It occurs when the pericardium becomes irritated or infected, leading to swelling and pain.PALO ALTO, Calif., April 16, 2025 (GLOBE NEWSWIRE) — Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain, following the formation of its proposed joint venture with IPMC Company, neurodegenerative and cardiometabolic disease, today announced that FDA has approved our request for the Orphan drug...

Continue reading

Logansport Financial Corp. Reports Net Earnings for the Quarter Ended March 31, 2025

LOGANSPORT, Ind., April 16, 2025 (GLOBE NEWSWIRE) — Logansport Financial Corp., (OTCBB, LOGN), parent company of Logansport Savings Bank, reported net earnings for the quarter ended March 31, 2025 of $377,000 or $0.61 per diluted share, compared to earnings in 2024 of $268,000 or $0.44 per diluted share. The Dividends paid to shareholders were $0.45 per share in the first quarter of 2025. Total loans were $172.3 million on March 31, 2025 compared to loans in 2024 of $168.5 million. Deposits were $229.5 million on March 31, 2025 compared to deposits in 2024 of $194.6 million. Total assets on March 31, 2025 were $266.2 million compared to assets in 2024 of $243.5 million. The statements contained in this press release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which...

Continue reading

CORRECTION NOTICE: Stride Announces Date for Third Quarter Fiscal Year 2025 Earnings Call

This press release has been updated to correct a link originally included in the second paragraph. The original release was issued on April 15, 2025. No other changes have been made. RESTON, VA, April 16, 2025 (GLOBE NEWSWIRE) — Stride Inc. (NYSE: LRN) announced today it plans to discuss its third quarter fiscal year 2025 financial results during a conference call scheduled for Tuesday, April 29, 2025 at 5:00 p.m. eastern time (ET). A live webcast of the call will be available at https://events.q4inc.com/attendee/598145147. To participate in the live call, investors and analysts should dial (800) 715-9871 (domestic) or +1 (646) 307-1963 (international) and provide the conference ID number 8901384. Please access the website at least 15 minutes prior to the start of the call. A replay of the call will be posted at https://events.q4inc.com/attendee/598145147...

Continue reading

Cosmos Health Reports Full-Year 2024 Results: Revenue Increases 2% to $54.43 Million While Operating Expenses Decline 24.2% to $19.86 Million

CHICAGO, April 16, 2025 (GLOBE NEWSWIRE) — Cosmos Health Inc. (“Cosmos Health” or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, today reported financial results for the full year ended December 31, 2024. Full Year 2024 Financial Highlights Income Statement: FY 2024 performance was marked by revenue growth, an increase in R&D investments, and a substantial reduction in operating expenses, while bottom-line results were impacted by the absence of non-recurring gains recognized in the prior year.Revenue increased by 2.0% to $54.43 million in FY 2024, from $53.38 million in the prior...

Continue reading

Press release – SPIE signs an agreement to acquire LTEC Group in poland

Cergy, April 16th, 2025 – SPIE, the independent European leader in multi-technical services in the areas of energy and communications, today announces the signing of an agreement for the acquisition of LTEC Group in Poland. Established in 2008, LTEC is an integrator of building automation and building management systems solutions. These functionalities are becoming a standard in large-scale facilities such as office buildings, hotels, shopping centres, industrial facilities, and hospitals. LTEC’s expertise helps its clients enhance energy efficiency, comfort, safety, and management of various installations in the projects they are involved in, by providing advanced automation solutions. LTEC generated approximately c.€19 million in revenue in 2024 and employs around 75 professionals, including many qualified engineers and specialists. Łukasz...

Continue reading

Aptorum Group Limited Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

Hong Kong, April 16, 2025 (GLOBE NEWSWIRE) — Aptorum Group Limited (NASDAQ: APM), a leading Biotechnology company, today announced that it has received a notification from the Nasdaq Stock Market LLC dated 15 April 2025 regarding non-compliance with the minimum bid price requirement of $1 per share, as per Nasdaq Listing Rule 5550(a)(2). The notification does not immediately affect the listing or trading of the company’s shares on Nasdaq. Aptorum Group Limited has been granted a 180-calendar-day grace period, until 14 October 2025, to regain compliance with the continued listing requirements. During this period, Aptorum Group Limited intends to evaluate all available options to restore compliance, including, if necessary, a reverse stock split. The company is committed to maintaining its Nasdaq listing and will take all reasonable...

Continue reading

Quadient Recognized in Analyst Report on Top AI Use Cases for Finance Automation

Quadient (Euronext Paris: QDT), a global automation platform powering secure and sustainable business connections, announces it has been recognized in a recent Forrester report on ways artificial intelligence (AI) is transforming accounts receivable (AR) processes. The report, “Top AI Use Cases for Accounts Receivable Automation In 2025,” includes mentions of Quadient AR for cash application and payment notice. Quadient considers its inclusion in the report as proof of the impact its AI- and machine learning-powered financial process automation offer, enhancing efficiency, accuracy, and decision-making capabilities. Manual AR, AP and invoice processes lead to inefficiencies, compliance risks, payment delays and increased vulnerability to fraud. Quadient’s Finance Automation cloud platform, including Quadient AR and Quadient AP, addresses...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.